Jane E. Mallewa

Blantyre, S, Malawi

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trial.

Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trial.

Journal: The Journal of infectious diseases
Published: December 17, 2025

Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial.

Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial.

Journal: The Journal of infectious diseases
Published: December 17, 2025

Incident hypertension among adults on ART in Malawi: a nested cohort study.

Incident hypertension among adults on ART in Malawi: a nested cohort study.

Journal: BMC infectious diseases
Published: July 30, 2025

Quantifying the bystander effect of antimicrobial use on the gut microbiome and resistome in Malawian adults.

Quantifying the bystander effect of antimicrobial use on the gut microbiome and resistome in Malawian adults.

Journal: Nature communications
Published: April 24, 2025

Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study.

Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study.

Journal: The Lancet. Global health
Published: October 08, 2024

DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial.

DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial.

Journal: Trials
Published: September 25, 2023

Genomic analysis of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli colonising adults in Blantyre, Malawi reveals previously undescribed diversity.

Genomic analysis of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli colonising adults in Blantyre, Malawi reveals previously undescribed diversity.

Journal: Microbial genomics
Published: June 14, 2023

Latent tuberculosis infection among adults attending HIV services at an urban tertiary hospital in Malawi.

Latent tuberculosis infection among adults attending HIV services at an urban tertiary hospital in Malawi.

Journal: AIDS (London, England)
Published: November 16, 2022

Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study.

Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study.

Journal: Medicine
Published: October 01, 2022

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.

Journal: BMC infectious diseases
Published: August 01, 2022

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.

Journal: medRxiv : the preprint server for health sciences
Published: July 21, 2022

Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.

Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.

Journal: PLOS global public health
Published: July 20, 2022
Showing 1-12 of 68

Last Updated: 09/26/2026